| Kathleen Elizabeth Schenker, MD | |
|
1600 Rockland Road, Delaware, DE 19803-3602 | |
| (302) 651-4641 | |
| (302) 651-4476 |
| Full Name | Kathleen Elizabeth Schenker |
|---|---|
| Gender | Female |
| Speciality | Diagnostic Radiology |
| Experience | 15 Years |
| Location | 1600 Rockland Road, Delaware, Delaware |
| Accepts Medicare Assignments | Yes. She accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1205169620 | NPI | - | NPPES |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| The Nemours Foundation | 9537072483 | 157 |
| The Nemours Foundation | 9537072483 | 157 |
News Archive
Hitachi Software Engineering America, Ltd. and OriGene Technologies, Inc. today announced a co-marketing agreement to jointly promote OriGene's multiplex assays built on Luminex xMAP/Bio-Plex technology and Hitachi Software's MasterPlex software suite for analysis and reporting of multiplex assay data.
While many people with epilepsy can control their seizures with medication, those unpredictable and involuntary changes in behavior and consciousness can be limiting for others. Neurologists writing in the International Journal of Epilepsy evaluated the application of smartphones in epilepsy care.
Nanoengineers at the University of California, San Diego have tested a temporary tattoo that both extracts and measures the level of glucose in the fluid in between skin cells. This first-ever example of the flexible, easy-to-wear device could be a promising step forward in noninvasive glucose testing for patients with diabetes.
A team of Vanderbilt researchers have demonstrated for the first time that a new type of gene therapy, called RNA interference, can heal a genetic disorder in a live animal.
› Verified 5 days ago
| Entity Name | The Nemours Foundation |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1386658615 PECOS PAC ID: 9537072483 Enrollment ID: O20040109000252 |
News Archive
Hitachi Software Engineering America, Ltd. and OriGene Technologies, Inc. today announced a co-marketing agreement to jointly promote OriGene's multiplex assays built on Luminex xMAP/Bio-Plex technology and Hitachi Software's MasterPlex software suite for analysis and reporting of multiplex assay data.
While many people with epilepsy can control their seizures with medication, those unpredictable and involuntary changes in behavior and consciousness can be limiting for others. Neurologists writing in the International Journal of Epilepsy evaluated the application of smartphones in epilepsy care.
Nanoengineers at the University of California, San Diego have tested a temporary tattoo that both extracts and measures the level of glucose in the fluid in between skin cells. This first-ever example of the flexible, easy-to-wear device could be a promising step forward in noninvasive glucose testing for patients with diabetes.
A team of Vanderbilt researchers have demonstrated for the first time that a new type of gene therapy, called RNA interference, can heal a genetic disorder in a live animal.
› Verified 5 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Kathleen Elizabeth Schenker, MD Po Box 191, Provider Enrollment Dept, Rockland, DE 19732-0191 Ph: (302) 651-6212 | Kathleen Elizabeth Schenker, MD 1600 Rockland Road, Delaware, DE 19803-3602 Ph: (302) 651-4641 |
News Archive
Hitachi Software Engineering America, Ltd. and OriGene Technologies, Inc. today announced a co-marketing agreement to jointly promote OriGene's multiplex assays built on Luminex xMAP/Bio-Plex technology and Hitachi Software's MasterPlex software suite for analysis and reporting of multiplex assay data.
While many people with epilepsy can control their seizures with medication, those unpredictable and involuntary changes in behavior and consciousness can be limiting for others. Neurologists writing in the International Journal of Epilepsy evaluated the application of smartphones in epilepsy care.
Nanoengineers at the University of California, San Diego have tested a temporary tattoo that both extracts and measures the level of glucose in the fluid in between skin cells. This first-ever example of the flexible, easy-to-wear device could be a promising step forward in noninvasive glucose testing for patients with diabetes.
A team of Vanderbilt researchers have demonstrated for the first time that a new type of gene therapy, called RNA interference, can heal a genetic disorder in a live animal.
› Verified 5 days ago